Theralase Technologies Inc.
TLTFF
$0.1475
$0.00977.04%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.11% | 9.95% | 9.22% | 3.66% | 9.81% |
| Total Depreciation and Amortization | -10.10% | -7.20% | -6.53% | -7.88% | -3.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 17.37% | 28.95% | -29.84% | -46.43% | -11.82% |
| Change in Net Operating Assets | 1,866.96% | 139.99% | -436.38% | 386.30% | -183.82% |
| Cash from Operations | 70.08% | 64.35% | -126.85% | 64.53% | 1.22% |
| Capital Expenditure | -1,566.67% | 41.67% | 22.22% | 73.91% | 69.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1,566.67% | 41.67% | 22.22% | 73.91% | 69.32% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -29.65% | 8.92% | -7.31% | -6.98% | -7.11% |
| Issuance of Common Stock | -74.37% | -59.50% | 186.70% | -37.45% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -77.81% | -63.25% | 190.90% | -39.40% | 5,438.27% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -282.60% | 69.11% | 43.54% | 644.81% | 106.19% |